Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Long-acting injectable (LAI) is a kind of pharmaceutical for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication. Rather than the daily pill-taking required with oral antipsychotics, LAI antipsychotics are administered by injection at two to four weeks intervals.
The report details the trend, potential and market size of Long-Acting Injectables market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Long-Acting Injectablesmarket, defines the market attractiveness level of Long-Acting Injectables market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Long-Acting Injectables industry, describes the types of Long-Acting Injectables market, the applications of major players and the market size, and deeply analyzes the current situation of the global Long-Acting Injectables market and the development prospects and opportunities of Long-Acting Injectables industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Long-Acting Injectables market in Chapter 13.
By Player:
Johnson and Johnson
Eli Lilly
Pfizer
Otsuka
Sanofi
GlaxoSmithKline
Alkermes
By Type:
Small and Middle Sized Molecule
Large Sized Molecule
By End-User:
Schizophrenia
Other Psychotic Disorders
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Long-Acting Injectables Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Long-Acting Injectables Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Long-Acting Injectables Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Long-Acting Injectables Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Long-Acting Injectables Market Analysis and Outlook to 2022
-
7.1 Global Long-Acting Injectables Consumption (2017-2022)
-
7.2 United States Long-Acting Injectables Consumption (2017-2022)
-
7.3 Europe Long-Acting Injectables Consumption (2017-2022)
-
7.4 China Long-Acting Injectables Consumption (2017-2022)
-
7.5 Japan Long-Acting Injectables Consumption (2017-2022)
-
7.6 India Long-Acting Injectables Consumption (2017-2022)
-
7.7 South Korea Long-Acting Injectables Consumption (2017-2022)
8 Region and Country-wise Long-Acting Injectables Market Analysis and Outlook to 2028
-
8.1 Global Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.2 United States Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.3 Europe Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.4 China Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.5 Japan Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.6 India Long-Acting Injectables Consumption Forecast (2022-2028)
-
8.7 South Korea Long-Acting Injectables Consumption Forecast (2022-2028)
9 Global Long-Acting Injectables Market Outlook by Types and Applications to 2022
-
9.1 Global Long-Acting Injectables Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Small and Middle Sized Molecule Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Large Sized Molecule Consumption and Growth Rate (2017-2022)
-
9.2 Global Long-Acting Injectables Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Schizophrenia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Other Psychotic Disorders Consumption and Growth Rate (2017-2022)
10 Global Long-Acting Injectables Market Outlook by Types and Applications to 2028
-
10.1 Global Long-Acting Injectables Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Small and Middle Sized Molecule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Large Sized Molecule Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Long-Acting Injectables Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Other Psychotic Disorders Consumption Forecast and Growth Rate (2022-2028)
11 Global Long-Acting Injectables Import and Export Analysis (Top 5 Countries)
-
11.1 Global Long-Acting Injectables Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Long-Acting Injectables Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Long-Acting Injectables Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Long-Acting Injectables Market Competitive Analysis
-
14.1 Johnson and Johnson
-
14.1.1 Johnson and Johnson Company Details
-
14.1.2 Johnson and Johnson Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson and Johnson Long-Acting Injectables Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Long-Acting Injectables Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Long-Acting Injectables Product and Service
-
14.4 Otsuka
-
14.4.1 Otsuka Company Details
-
14.4.2 Otsuka Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Otsuka Long-Acting Injectables Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Long-Acting Injectables Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline Long-Acting Injectables Product and Service
-
14.7 Alkermes
-
14.7.1 Alkermes Company Details
-
14.7.2 Alkermes Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Alkermes Long-Acting Injectables Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Long-Acting Injectables
-
Figure Long-Acting Injectables Picture
-
Table Global Long-Acting Injectables Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long-Acting Injectables Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Long-Acting Injectables Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Long-Acting Injectables Consumption by Country (2017-2022)
-
Figure United States Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Table Europe Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Figure China Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Figure Japan Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Figure India Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Figure South Korea Long-Acting Injectables Consumption and Growth Rate (2017-2022)
-
Figure Global Long-Acting Injectables Consumption Forecast by Country (2022-2028)
-
Figure United States Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Long-Acting Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small and Middle Sized Molecule Consumption and Growth Rate (2017-2022)
-
Figure Global Large Sized Molecule Consumption and Growth Rate (2017-2022)
-
Figure Global Schizophrenia Consumption and Growth Rate (2017-2022)
-
Figure Global Other Psychotic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Small and Middle Sized Molecule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large Sized Molecule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Schizophrenia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Psychotic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Long-Acting Injectables Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Long-Acting Injectables Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Long-Acting Injectables Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Long-Acting Injectables Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Long-Acting Injectables Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Long-Acting Injectables Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Long-Acting Injectables Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Long-Acting Injectables Product and Service
-
Table Alkermes (Foundation Year, Company Profile and etc.)
-
Table Alkermes Long-Acting Injectables Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkermes Long-Acting Injectables Product and Service
-
